Back to search

Article

Successful treatment of COVID-19 with remdesivir in the absence of humoral immunity

2020-09-23

Abstract excerpt

The response to the coronavirus disease 2019 (COVID-19) pandemic has been hampered by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antiviral therapy. Here we report the successful use of remdesivir in a patient with COVID-19 and the prototypic genetic antibody deficiency X-linked agammaglobulinaemia (XLA). Despite evidence of complement activation and a robust T cell response,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d3874dca-66ef-572c-9273-45d9339384ca
DOI
10.21203/rs.3.rs-79022/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Successful treatment of COVID-19 with remdesivir in the absence of humoral immunityDOI 10.21203/rs.3.rs-79022/v1
Persistent SARS-CoV-2 PCR positivity despite treatment in immunodeficient patientsSemantic proximity
Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemiaSemantic proximity
Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in miceSemantic proximity
Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child.Semantic proximity
Pharmacometric assessment of the <i>in vivo</i> antiviral activity of ivermectin in early symptomatic COVID-19Semantic proximity
Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)Semantic proximity
Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and PharmacodynamicsSemantic proximity
Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases.Semantic proximity
Select a neighboring publication to make it the new centre.